A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin

Management of systemic mastocytosis is an emerging challenge which requires a multidisciplinary diagnostic approach and personalized treatment strategy. Midostaurin can rapidly reduce the disease burden, also in cladribine refractory cases.

Detalles Bibliográficos
Autores principales: Sciumè, Mariarita, Serpenti, Fabio, Muratori, Simona, Pravettoni, Valerio, Ulivieri, Fabio Massimo, Croci, Giorgio Alberto, Migliorini, Anna Chiara, Esposito, Andrea, Goldaniga, Maria Cecilia, Saporiti, Giorgia Natascia, Galassi, Giulia, Baldini, Luca, Onida, Francesco, Grifoni, Federica Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869399/
https://www.ncbi.nlm.nih.gov/pubmed/33598282
http://dx.doi.org/10.1002/ccr3.3717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869399/
https://www.ncbi.nlm.nih.gov/pubmed/33598282
http://dx.doi.org/10.1002/ccr3.3717

Ejemplares similares